Digifab Injection, Powder, Lyophilized, For Solution
Product Images NDC 50633-120

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Digifab (NDC 50633-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Digifab 01

Digifab 01
DigiFabĀ® is a registered trademark used for a medication available for intravenous injection. The medication comes in a package containing one vial with a lyophilized powder made up of 40mg Digoxin Immune Fab (Ovine), 75mg (approx) Mannitol USP, and buffer. No preservatives are contained, and it must be mixed with sterile water for injection. This medication is manufactured and distributed by BTG International Inc. and is not to be frozen. It is recommended to use immediately after reconstitution.*
FDA Label Image

Carton Label (Digifab 02)

Carton Label (Digifab 02)
This appears to be a product label for DigiFabĀ®, an ovine-based medication used to treat digoxin toxicity. The label includes dosage information and storage instructions, as well as a warning not to freeze the medication. The text also references NDC numbers and other alphanumeric codes that may be useful for medical professionals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.